	Prognostic value of the preoperative C-reactive protein-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma. PLoS One Qin M, Feng Z, Zhang C, Song W, Wang K, Chen Z. PMID: 42961929 [PubMed - indexed for MEDLINE]
	Reassessing the diagnostic value of spectral CT-derived parameters for pathological grading of urothelial carcinoma of the bladder. Abdom Radiol (NY) Wang X, Du S, Hu J, Liu X, Wen Z, Lin F. PMID: 42961642 [PubMed - as supplied by publisher]
	Malignant solitary fibrous tumour of the prostate with a concomitant prostatic adenocarcinoma - A case report and review of the literature. Indian J Pathol Microbiol Dhanasekaran V, Cima L. PMID: 42961580 [PubMed - indexed for MEDLINE]
	Histoplasma colonization of metastatic renal cell carcinoma (RCC) cells in a case of adrenal histoplasmosis involved by metastatic eosinophilic solid cystic RCC with rhabdoid differentiation. Indian J Pathol Microbiol Hota S, Chakrabarti S. PMID: 42961577 [PubMed - indexed for MEDLINE]
	PD-L1 Expression in muscle-invasive bladder carcinoma: correlation with tumor-stroma ratio and clinicopathological parameters. Indian J Pathol Microbiol Chaturvedi A, Nisam I, Mallya V, Mandal S, Singh CB. PMID: 42961563 [PubMed - indexed for MEDLINE]
	Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis. J Oncol Pharm Pract Cruz Castillo Y, Chen Liang A, Samperio VM, Bentley A, Roberts Trinidad EO, Codreanu I, Dasanu CA. PMID: 42961340 [PubMed - as supplied by publisher]
	Impact of the Multimodal Protocol on the Outcomes of Cancer Patients Undergoing Radical Cystectomy. Rev Col Bras Cir Petry MA, Polakowski CB, Rabito EI, Kool R, Luz M, Pereira JL, Sato BMK, Lombardi RG, Tomasich FDS. PMID: 42961271 [PubMed - indexed for MEDLINE]
	The current landscape of bladder-sparing therapies in BCG-refractory high-risk nonmuscle-invasive bladder cancer. Curr Urol Gu Y, He W, Yu X, Jiang C, Zhang Z, Xu C, Zeng S. PMID: 42960368 [PubMed]
	Explainable artificial intelligence in prostate and bladder cancer: A review of imaging, digital pathology, molecular profiling, and clinical data. Curr Urol Diamantidis D, Tsakaldimis G, Smyrlis N, Chousein C, Kafalis C, Foutzitzi K, Deligeorgiou E, Panagiotopoulos N, Lailisidis S, Georgellis C, Giannopoulos S, Giannakopoulos S, Kalaitzis C. PMID: 42960345 [PubMed]
	4Kscore as a Pre-MRI Reflex Test for Men with PSA 1.80-2.99â€¯ng/ml in the GÃ¶teborg-2 Prostate Cancer Screening Trial. Eur Urol Open Sci Möller F, Josefsson A, Månsson M, Carlsson S, Lilja H, Spyratou V, Wallström J, Hugosson J, Arnsrud Godtman R. PMID: 42960148 [PubMed]
	Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions. Curr Urol Rival PM, Jiang J, Qu LG, O'Brien J, Gilmore P, Corcoran N. PMID: 42960082 [PubMed]
	Ultrasound with nerve stimulation versus ultrasound alone for obturator nerve block in transurethral resection of bladder tumor: A systematic review and meta-analysis. Saudi J Anaesth Hu Q, Gan L, Ouyang C, Peng L, Zhong C, Wang S. PMID: 42960054 [PubMed]
	Targeting lipid metabolism to overcome therapeutic resistance in renal cell carcinoma: Mechanisms and emerging strategies. Curr Urol Feng Y, Zhang S, Li J, Yue D, Wang Y. PMID: 42960049 [PubMed]
	ADAM19 Promotes EMT-Related Changes and Serves as a Prognostic Marker in Circulating Tumor Cells of Renal Cell Carcinoma. Cancer Sci He M, Li M, Ma Y, Chen Z, Guo L, Wang X, Wang W, Chong T, Wang Z. PMID: 42958621 [PubMed - as supplied by publisher]
	Factors associated with Gleason score upgrading in biopsy-proven Gleason 6 prostate cancer: a retrospective cohort study. BMC Urol Guo CH, Zhu LY, Chi SP, Tan X, Luan Y, Ding XF. PMID: 42958541 [PubMed - indexed for MEDLINE]
	Impact of MRI-to-surgery interval on pathological upstaging after robot-assisted radical prostatectomy: a real-world cohort study. BMC Urol Farag K, Mohamed T, Elhashamy H, Ramez M, Manivannan S, Kailavasan M, Alevizopoulos A. PMID: 42958519 [PubMed - indexed for MEDLINE]
	Integration of bulk RNA-seq data with single-cell RNA-seq data to identify urinary biomarkers derived from prostate tumor tissues. BMC Urol Shen Y, Guo Y, Wu Y, Dai L, Liu J, Zhu T, Xu J, Li H, Yang R, Cai Z, Fei X. PMID: 42958227 [PubMed - indexed for MEDLINE]
	Predicting malignant histology in small renal masses: the role of anatomical and radiological nephrometry scores. BMC Urol Çetinkaya MB, Kartal , Alk, Atlano, , Ço, Sevim M, Aras B. PMID: 42958163 [PubMed - indexed for MEDLINE]
	Overexpression of small nucleolar RNA host gene family members predicts poor bladder cancer prognosis: based on a systematic review and meta-analysis. BMC Cancer Hao WP, Lin ZB, Ke L, Liu HJ, Su CQ, Fu LM, Hong SB. PMID: 42958110 [PubMed - indexed for MEDLINE]
	Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial. Prostate Cancer Prostatic Dis Guer M, Lazarovich A, Luger F, Cash H, Ghai S, Urdaneta-Salegui LF, Pavlovich CP, Brito J, Shore ND, Struck JP, Schostak M, Harland N, Rodriguez-Socarrás M, Brisbane WG, Lughezzani G, Toledano H, Ouertani MS, Macek P, Fung C, Tu W, Gusenleitner A, Günzel K, Incze PF, George AK, Pereira JG, Jansen R, Renzulli J 2nd, Klotz L, Kinnaird A. PMID: 42957822 [PubMed - as supplied by publisher]

Articles 1 - 20 / 182612

Page 1 of 9131



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy